86 related articles for article (PubMed ID: 19641530)
1. Efficient delivery of angiostatin K1-5 into tumors following insertion of an NGR peptide into adenovirus capsid.
Jullienne B; Vigant F; Muth E; Chaligné R; Bouquet C; Giraudier S; Perricaudet M; Benihoud K
Gene Ther; 2009 Dec; 16(12):1405-15. PubMed ID: 19641530
[TBL] [Abstract][Full Text] [Related]
2. Integrin αvβ3 and disulfide bonds play important roles in NGR-retargeted adenovirus transduction efficiency.
Nestić D; Hozić A; Brkljača Z; Butorac A; Pažur K; Jullienne B; Cindrić M; Ambriović-Ristov A; Benihoud K; Majhen D
Life Sci; 2022 Feb; 291():120116. PubMed ID: 34740576
[TBL] [Abstract][Full Text] [Related]
3. NGR-bearing human adenovirus type 5 infects cells in flotillin- or caveolin-mediated manner depending on the NGR insertion site.
Božinović K; Nestić D; Grellier E; Raddi N; Cornilleau G; Ambriović-Ristov A; Benihoud K; Majhen D
Biomater Adv; 2023 Dec; 155():213681. PubMed ID: 37944448
[TBL] [Abstract][Full Text] [Related]
4. [Adenovirus mediated angiostatin gene therapy for ovarian cancer: experiment with nude mice].
Jia CR; Yang SY; Han SY; Sun L
Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(31):2204-8. PubMed ID: 19080673
[TBL] [Abstract][Full Text] [Related]
5. Gene delivery into malignant glioma by infectivity-enhanced adenovirus: in vivo versus in vitro models.
Van Houdt WJ; Wu H; Glasgow JN; Lamfers ML; Dirven CM; Gillespie GY; Curiel DT; Haviv YS
Neuro Oncol; 2007 Jul; 9(3):280-90. PubMed ID: 17522331
[TBL] [Abstract][Full Text] [Related]
6. Anti-tumor efficacy of human angiostatin using liver-mediated adeno-associated virus gene therapy.
Lalani AS; Chang B; Lin J; Case SS; Luan B; Wu-Prior WW; VanRoey M; Jooss K
Mol Ther; 2004 Jan; 9(1):56-66. PubMed ID: 14741778
[TBL] [Abstract][Full Text] [Related]
7. Adenoviral vector expressing murine angiostatin inhibits a model of breast cancer metastatic growth in the lungs of mice.
Gyorffy S; Palmer K; Gauldie J
Am J Pathol; 2001 Sep; 159(3):1137-47. PubMed ID: 11549607
[TBL] [Abstract][Full Text] [Related]
8. Targeting EGFR with metabolically biotinylated fiber-mosaic adenovirus.
Pereboeva L; Komarova S; Roth J; Ponnazhagan S; Curiel DT
Gene Ther; 2007 Apr; 14(8):627-37. PubMed ID: 17251987
[TBL] [Abstract][Full Text] [Related]
9. Disulfide bond formation in NGR fiber-modified adenovirus is essential for retargeting to aminopeptidase N.
Majhen D; Gabrilovac J; Eloit M; Richardson J; Ambriović-Ristov A
Biochem Biophys Res Commun; 2006 Sep; 348(1):278-87. PubMed ID: 16876116
[TBL] [Abstract][Full Text] [Related]
10. High level of stabilized angiostatin mediated by adenovirus delivery does not impair the growth of human neuroblastoma xenografts.
Joseph JM; Bouquet C; Opolon P; Morizet J; Aubert G; Rössler J; Gross N; Griscelli F; Perricaudet M; Vassal G
Cancer Gene Ther; 2003 Nov; 10(11):859-66. PubMed ID: 14605672
[TBL] [Abstract][Full Text] [Related]
11. Targeted adenovirus vectors.
Mizuguchi H; Hayakawa T
Hum Gene Ther; 2004 Nov; 15(11):1034-44. PubMed ID: 15610604
[TBL] [Abstract][Full Text] [Related]
12. Viral vector-targeted antiangiogenic gene therapy utilizing an angiostatin complementary DNA.
Tanaka T; Cao Y; Folkman J; Fine HA
Cancer Res; 1998 Aug; 58(15):3362-9. PubMed ID: 9699667
[TBL] [Abstract][Full Text] [Related]
13. Effective antitumour mono- and combination therapy by gene delivery of angiostatin-like molecule and interleukin-12 in a murine hepatoma model.
Schmitz V; Tirado-Ledo L; Raskopf E; Rabe C; Wernert N; Wang L; Prieto J; Qian C; Sauerbruch T; Caselmann WH
Int J Colorectal Dis; 2005 Nov; 20(6):494-501. PubMed ID: 15864607
[TBL] [Abstract][Full Text] [Related]
14. Characterization of capsid-modified adenovirus vectors containing heterologous peptides in the fiber knob, protein IX, or hexon.
Kurachi S; Koizumi N; Sakurai F; Kawabata K; Sakurai H; Nakagawa S; Hayakawa T; Mizuguchi H
Gene Ther; 2007 Feb; 14(3):266-74. PubMed ID: 17006548
[TBL] [Abstract][Full Text] [Related]
15. A simplified system for constructing recombinant adenoviral vectors containing heterologous peptides in the HI loop of their fiber knob.
Mizuguchi H; Koizumi N; Hosono T; Utoguchi N; Watanabe Y; Kay MA; Hayakawa T
Gene Ther; 2001 May; 8(9):730-5. PubMed ID: 11406768
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of angiogenesis and tumor progression by hydrodynamic cotransfection of angiostatin K1-3, endostatin, and saxatilin genes.
Kim KS; Kim DS; Chung KH; Park YS
Cancer Gene Ther; 2006 Jun; 13(6):563-71. PubMed ID: 16410825
[TBL] [Abstract][Full Text] [Related]
17. Hexon-specific PEGylated adenovirus vectors utilizing avidin-biotin interaction.
Suzuki-Kouyama E; Katayama K; Sakurai F; Yamaguchi T; Kurachi S; Kawabata K; Nakagawa S; Mizuguchi H
Biomaterials; 2011 Feb; 32(6):1724-30. PubMed ID: 21106235
[TBL] [Abstract][Full Text] [Related]
18. Influence of fiber detargeting on adenovirus-mediated innate and adaptive immune activation.
Schoggins JW; Nociari M; Philpott N; Falck-Pedersen E
J Virol; 2005 Sep; 79(18):11627-37. PubMed ID: 16140740
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of angiostatin, endostatin and interferon-alpha(1) gene transfer on in vivo growth of human breast cancer cells.
Indraccolo S; Gola E; Rosato A; Minuzzo S; Habeler W; Tisato V; Roni V; Esposito G; Morini M; Albini A; Noonan DM; Ferrantini M; Amadori A; Chieco-Bianchi L
Gene Ther; 2002 Jul; 9(13):867-78. PubMed ID: 12080381
[TBL] [Abstract][Full Text] [Related]
20. Development of lentiviral vectors for antiangiogenic gene delivery.
Shichinohe T; Bochner BH; Mizutani K; Nishida M; Hegerich-Gilliam S; Naldini L; Kasahara N
Cancer Gene Ther; 2001 Nov; 8(11):879-89. PubMed ID: 11773978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
